Older Adult Cancer Survivors (OACS) - Behavioral Activation (BA) for Survivorship

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, NY
SurvivorshipBehavioral Activation - Behavioral
Eligibility
65+
All Sexes
What conditions do you have?
Select

Study Summary

This trial tests if psychotherapy delivered by phone/video can help treat depression in older cancer survivors.

Eligible Conditions
  • Survivorship

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 2 months post intervention

2 months post intervention
Difference of Patient Health Questionnaire 9 (PHQ-9) scores between study groups

Trial Safety

Phase-Based Safety

2 of 3
This is further along than 68% of similar trials

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Older Adult Cancer Survivors (OACS) - Behavioral Activation (BA)
1 of 2
Older Adult Cancer Survivors (OACS) - Supportive Psychotherapy (SP)
1 of 2

Experimental Treatment

66 Total Participants · 2 Treatment Groups

Primary Treatment: Older Adult Cancer Survivors (OACS) - Behavioral Activation (BA) · No Placebo Group · Phase 2

Older Adult Cancer Survivors (OACS) - Behavioral Activation (BA)
Behavioral
Experimental Group · 1 Intervention: Behavioral Activation · Intervention Types: Behavioral
Older Adult Cancer Survivors (OACS) - Supportive Psychotherapy (SP)
Behavioral
Experimental Group · 1 Intervention: Supportive Psychotherapy · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Activation
2013
Completed Phase 3
~2920
Supportive Psychotherapy
2008
Completed Phase 2
~1150

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 months post intervention

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,863 Previous Clinical Trials
591,541 Total Patients Enrolled
Rebecca Saracino, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

Eligibility Criteria

Age 65+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Are there any vacancies for the current clinical trial?

"The clinical trial is presently in search of volunteers, which was first posted on October 6th 2022 and has since been amended on February 15th 2023." - Anonymous Online Contributor

Unverified Answer

Has the Older Adult Cancer Survivors (OACS) - Behavioral Activation (BA) protocol gained FDA endorsement?

"The safety of Older Adult Cancer Survivors (OACS) - Behavioral Activation (BA) was assessed to be a 2 on the 1-3 scale due to it currently being in its second phase. This suggests that while there is evidence of some level of safety, efficacy has yet to be confirmed." - Anonymous Online Contributor

Unverified Answer

How many subjects are actively participating in this clinical experiment?

"Affirmative. According to information on clinicaltrials.gov, this medical investigation is actively recruiting candidates. Originally posted on October 6th 2022 and revised as recently as February 15th 2023, the trial looks for 66 patients at 1 site in particular." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.